SuperworthColgate-Palmolive CL
- Market cap
- $75B
- PE
- 37.3×
- 10y median 27.2×
- Forward PE
- 24.0×
- 10y median 24.7×
- Price to sales
- 3.6×
- EV/EBIT
- 20.2×
- Revenue, 12 months
- $21B
- +5% on a year ago
- Net margin
- 9.7%
- Free cash flow yield
- 5.1%
Colgate-Palmolive trades at 37.3× trailing earnings, pricier than 88% of the last ten years. Revenue was $21B over the last twelve months, up 5% on a year earlier with a 10% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $4.9B+10% | $5B+7% | $5.1B+6% | $5.1B+5% | $5B+2% | $4.9B−0% | $4.9B−3% | $5.1B+1% | $5.1B+2% | $5.2B+6% | $5.3B+8% | $5.4B+5% | |
| Cost of revenue | $2B+7% | $2B−3% | $2B−2% | $2B−2% | $2B−4% | $2B−2% | $1.9B−5% | $2B+3% | $2.1B+6% | $2.1B+6% | $2.1B+9% | $2.1B+1% |
| Gross profit | $2.9B+13% | $3B+15% | $3B+12% | $3.1B+10% | $3.1B+7% | $3B+1% | $3B−2% | $3.1B+0% | $3B−1% | $3.1B+6% | $3.2B+8% | $3.3B+7% |
| SG&A | $1.8B+12% | $1.8B+10% | $1.9B+9% | $1.9B+10% | $2B+9% | $1.9B+5% | $1.9B−1% | $2B+1% | $2B−0% | $2.1B+9% | $2.1B+9% | $2.1B+9% |
| $1B+9% | $1.1B+431% | $1B+15% | $1.1B+12% | $1.1B+4% | $1.1B−1% | $1.1B+3% | $1.1B−1% | $1.1B−1% | $92M−91% | $964M−10% | $1B−6% | |
| Interest expense | $58M+45% | $62M+13% | $73M+35% | $78M+35% | $74M+28% | $66M+7% | $66M−10% | $71M−9% | $67M−10% | $64M−3% | $62M−6% | $62M−13% |
| Pre-tax income | $956M+7% | $988M+649% | $967M+72% | $1B+14% | $986M+3% | $993M+1% | $953M−1% | $1B−0% | $992M+1% | $108M−89% | $892M−6% | $950M−6% |
| $209M−1% | $228M+156% | $238M+62% | $243M−31% | $210M+1% | $214M−6% | $227M−5% | $234M−4% | $226M+8% | $113M−47% | $211M−7% | $231M−1% | |
| Net income | $708M+15% | $718M+14260% | $683M+84% | $731M+46% | $737M+4% | $739M+3% | $690M+1% | $743M+2% | $735M−0% | −$37M | $646M−6% | $693M−7% |
| $0.86+16% | $0.87+8600% | $0.83+84% | $0.89+48% | $0.90+5% | $0.90+3% | $0.85+2% | $0.91+2% | $0.91+1% | −$0.05 | $0.80−6% | $0.86−6% | |
| 827.3M−1% | 825.3M−1% | 825.9M−1% | 823.7M−1% | 822.5M−1% | 820.2M−1% | 815M−1% | 813.3M−1% | 810.2M−2% | 804.8M−2% | 805.1M−1% | 801.8M−1% |
EPS, diluted: Q4 FY08 and Q4 FY09: quarter's net income to common over its shares, to the cent, the shares from counts implied by EPS, near the year's EPS less the nine months'. 5 periods, Q4 FY21 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q3 FY08 and Q1 FY09: not printed by the filing, worked out from its own lines. 15 periods, Q4 FY09 to Q4 FY24: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY15 and Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $5.3B | $5.3B to $5.4B | $0.93 | $0.90 to $0.95 | 13 |
| Q4 FY26 | $5.4B | $5.4B to $5.4B | $0.96 | $0.92 to $0.98 | 12 |
| Q1 FY27 | $5.5B | $5.4B to $5.5B | $0.99 | $0.98 to $1.00 | 5 |
| Q2 FY27 | $5.5B | $5.5B to $5.5B | $1.03 | $1.03 to $1.05 | 5 |
| Q3 FY27 | $5.5B | $5.5B to $5.6B | $1.01 | $1.00 to $1.02 | 5 |
| Q4 FY27 | $5.6B | $5.5B to $5.6B | $1.05 | $1.04 to $1.06 | 5 |
| Q1 FY28 | $5.7B | $5.7B to $5.7B | $1.07 | $1.06 to $1.08 | 6 |
| Q2 FY28 | $5.7B | $5.7B to $5.8B | $1.11 | $1.11 to $1.13 | 6 |
Peers
Companies in Household & Personal Products nearest Colgate-Palmolive's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| CLColgate-Palmolive | $75B | 37.3× | 27.2× | 24.0× | 3.6× | +5% | 9.7% |
| ELEstée Lauder Companies | $39.3B | 222× | 44.6× | 32.8× | 2.6× | +5% | 1.2% |
| KVUEKenvue | $37.6B | 22.5× | 24.1× | 16.2× | 2.4× | +2% | 10.8% |
| KMBKimberly-Clark | $36.6B | 18.7× | 21.4× | 15.8× | 2.2× | +1% | 11.8% |
| CHDChurch & Dwight | $25B | 33.8× | 29.4× | 26.9× | 4.0× | +3% | 12.0% |
| PGProcter & Gamble | $374.3B | 24.3× | 25.2× | 23.3× | 4.3× | +4% | 18.2% |
| AVYAvery Dennison | $13.8B | 19.9× | 23.4× | n/m | 1.5× | +6% | 7.6% |
| Peer median | $37.1B | 23.4× | 24.7× | 23.3× | 2.5× | +3% | 11.3% |
More on Colgate-Palmolive
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #5of 15Household and personal products stocks with the fastest revenue growth
- #6of 15Household and personal products stocks with the highest profit margins
- #8of 15Household and personal products stocks with the highest free cash flow yield
- #9of 11Household and personal products stocks with the lowest PE ratio
- #9of 10Household and personal products stocks with the fastest earnings growth
Its groups
About
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
Valuation data, not investment advice. Prices as of .